Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02763202 · ClinicalTrials.gov registry record · NA
Aiming to Improve Readmissions Through InteGrated Hospital Transitions
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,876
- Enrollment target
NCT02763202: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT02763202 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,876 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02763202, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,876 participants
- Enrollment target
Study Summary
The purpose of this study is to better enhance transitions of care for the highest risk, complex patients, Carolinas HealthCare System (CHS) has designed an Integrated Practice Unit, called Transition Services (CHS-TS).CHS-TS aims to improve patient outcomes through innovative approaches that leverage analytics and technology, while bridging care coordination and communication gaps. During their hospitalization, CHS-TS patients enter into a transition pathway that includes the following key services: integrated access to medical, pharmacist, and specialty providers; access to CHS disease specific management programs; dedicated care management services delivered in home and at the clinic; lab and infusion services; palliative care consultations when appropriate; and paramedicine for 24 hour support. AIRTIGHT (Aiming to Improve Readmissions Through InteGrated Hospital Transitions) is a pragmatic, randomized quality improvement evaluation, which seeks to evaluate the effects of the role-out of CHS-TS services for patients at high risk for a 30-day readmission. AIRTIGHT will test the hypothesis that patients that receive care through CHS-TS will have a lower all cause, 30-day readmission rate than patients that receive usual care.
Primary Outcome
Index visit as defined by the Centers for Medicaid and Medicare Services (CMS) and inclusion of observation patients at any CHS facility
Interventions
- OTHER CHS Transition Services
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,876 participants |
| Start Date | 2016-02-08 |
| Est. Completion | 2017-04-30 |
| Phase | NA |
What the finished NCT02763202 record still lists
NCT02763202 is an interventional study that assigns participants to a tested intervention. Its 1,876 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% higher).
The record links to 0 conditions, and to 1 intervention - of which CHS Transition Services is the first listed.
NCT02763202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02763202 about?
NCT02763202 is a clinical study titled "Aiming to Improve Readmissions Through InteGrated Hospital Transitions". The purpose of this study is to better enhance transitions of care for the highest risk, complex patients, Carolinas HealthCare System (CHS) has designed an Integrated Practice Unit, called Transition Services (CHS-TS).CHS-TS aims to improve patient outcomes through innovative approaches that levera...
What is the current status of trial NCT02763202?
This trial is currently completed. It is a NA study. The enrollment target is 1,876 participants. The study started on 2016-02-08. Estimated completion is 2017-04-30.
What interventions are being tested in trial NCT02763202?
The interventions under investigation include: CHS Transition Services (OTHER).
Who is sponsoring clinical trial NCT02763202?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02763202's enrollment target sits among peer trials
1,876 56th of 2000 higher than 1,945 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05675410 · 1,875 participants · Phase 3
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- NCT06891898 · 1,875 participants
The iLet Experience Study
- NCT07356089 · 1,875 participants
Twiist Postmarket Surveillance Study for Type 1 Diabetes
- NCT07203313 · 1,872 participants · NA
Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI